IL‐1β increases necrotic neuronal cell death in the developing rat hippocampus after status epilepticus by activating type I IL‐1 receptor (IL‐1RI)

Abstract

Interleukin-1β (IL-1β) is associated with seizure-induced neuronal cell death in the adult brain. The contribution of IL-1β to neuronal injury induced by status epilepticus (SE) in the immature brain remains unclear. In the present study, we investigated the effects of IL-1β administration on hippocampal neuronal cell death associated with SE in the immature brain, and the role of the type I receptor of IL-1β (IL-1RI). SE was induced with lithium-pilocarpine in 14-days-old (P14) rat pups. Six hours after SE onset, pups were i.c.v. injected in the right ventricle with IL-1β (0, 0.3, 3, 30, or 300 ng), 30 ng of IL-1RI antagonist (IL-1Ra) alone, or 30 ng of IL-1Ra plus 3ng of IL-1β. As control groups, pups without seizures were injected with 3 ng of IL-1β or vehicle. Twenty-four hours after SE onset, neuronal cell death in the CA1 field of dorsal hippocampus was assessed by hematoxylin-eosin, Fluoro-Jade B and in vivo propidium iodide (PI) staining; expression of active caspase-3 (aCas-3) was also determined, using immunohistochemistry. The concentration-response curve of IL-1β showed a bell-shape. Only pups injected with 3 ng of IL-1β after SE showed a significant increase in the number of cells with eosinophilic cytoplasm and pyknotic nuclei, as well as F-JB positive cells with respect to the vehicle group. This effect was prevented when IL-1β was injected with IL-1Ra. Injection of 3 ng of IL-1β increased the number of PI-positive cells in CA1 area after SE. Injection of 3 ng of IL-1β did not produce hippocampal cell death in rats without seizures. Active caspase-3 expression was not observed after treatments in hippocampus. The activation of the IL-1β/IL-1RI system increases necrotic neuronal cell death caused by SE in rat pups.

Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina

“…IL-1 is expressed at low levels under normal conditions and requires induction at both transcriptional and translational levels. Elevated concentrations of IL-1 in vitro are toxic to neurons ( Hailer et al., 2005 ; Ye et al., 2013 ), and elevation of IL-1 in vivo is associated with excessive growth of dystrophic neurites in Alzheimer’s disease models ( Medel-Matus et al., 2014 ). Also, neurodegenerative effects of IL-1 are reported in brain injury ( Murray et al., 2015 ), endotoxemia ( Cardona et al., 2006b ), and multiple sclerosis ( Hooper-van et al., 2003 ; Heidary et al., 2014 ; Peelen et al., 2015 ).…”

Neuroprotective Effects of a Smoothened Receptor Agonist against Early Brain Injury after Experimental Subarachnoid Hemorrhage in Rats

“…Injured neurons were identified by their acidophilic (eosinophilic) cytoplasm and pyknotic nuclei with HE staining (Medel-Matus et al, 2014). Three microscope areas (40×) in PFC were obtained and counted damaged cells by a blind manner.…”

Antenatal Suppression of IL-1 Protects against Inflammation-Induced Fetal Injury and Improves Neonatal and Developmental Outcomes in Mice

“…To date, there is no therapeutic molecule available to prevent/ alleviate pathological inflammatory processes in pregnant women at risk for PTB. Of all mediators implicated in gestational inflammation and the onset of neonatal morbidities, IL-1, which is a potent pleiotropic cytokine central to numerous inflammatory processes and capable of mounting an acute inflammatory response via ubiquitously expressed IL-1R, exerts a major detrimental role, as suggested by a broad body of evidence, including: 1) increased levels of IL-1b and IL-1Ra are early markers of neonatal injuries of the lung, intestine, and brain (21)(22)(23)(24), and such injuries can be recreated in rodent and ovine models via overexpression or administration of IL-1 (25)(26)(27); 2) antagonism of the IL-1 receptor, IL-1b, or inhibition of the cleavage and release of IL-1b by targeting caspase-1 activity provides improvement in outcomes of perinatal injuries to the aforementioned organs, including when triggered by upstream proinflammatory stressors (17,19,(28)(29)(30)(31)(32); and 3) inflammatory concentrations of IL-1b elicit neuromicrovascular decay (33), curtail hippocampal neuron differentiation (34), and consequently lead to seizures wherein IL-1b further contributes to brain injury (35). Therefore, IL-1 represents a target of high interest and potential to improve health outcomes in premature infants.…”